Marshall Wace’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,300
Closed -$865K 2493
2023
Q2
$865K Sell
15,300
-31,500
-67% -$1.75M ﹤0.01% 1780
2023
Q1
$2.71M Buy
46,800
+32,200
+221% +$2.17M 0.01% 1290
2022
Q4
$1.06M Buy
+14,600
New +$1.05M ﹤0.01% 2059
2021
Q4
Sell
-5,100
Closed -$314K 4131
2021
Q3
$314K Buy
+5,100
New +$307K ﹤0.01% 2627
2021
Q2
Sell
-5,000
Closed -$304K 2895
2021
Q1
$304K Buy
+5,000
New +$276K ﹤0.01% 2123

Other funds holding MET

Marshall Wace's MET Position: Q1 2026 in Review

Marshall Wace sold out of MetLife (MET) in Q1 2026, closing a stake of 3,600 shares — an estimated $284K sold.

Marshall Wace first reported a position in MET in Q1 2015 and held it in 20 quarters. The position peaked at $80.7M in Q4 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Marshall Wace reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 3,600 MetLife shares in Q1 2026, an estimated $284K.
  • Marshall Wace first reported a position in MetLife in Q1 2015 and held it in 20 quarters.
  • Marshall Wace's MetLife position peaked at $80.7M in Q4 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.